| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 54,940 | Sold Some | -4,100 | -6.94 % | $1,339,437 | $1,296,584 | $-42,853 | -3.19 % | $3,198 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2009-08-03 | 2009-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 59,040 | Sold Some | -25,960 | -30.54 % | $1,597,032 | $1,393,344 | $-203,688 | -12.75 % | $89,562 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2009-05-04 | 2009-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 85,000 | Added More | 235 | 0.27 % | $3,207,900 | $2,006,000 | $-1,201,900 | -37.46 % | $-3,323 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2009-02-13 | 2008-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 84,765 | Added More | 10,000 | 13.37 % | $7,416,090 | $2,000,454 | $-5,415,636 | -73.02 % | $-638,900 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2008-11-06 | 2008-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 74,765 | No Change | 0 | 0 % | $5,306,820 | $1,764,454 | $-3,542,366 | -66.75 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2008-08-14 | 2008-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 74,765 | Added More | 6,100 | 8.88 % | $4,927,761 | $1,764,454 | $-3,163,307 | -64.19 % | $-258,091 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2008-05-14 | 2008-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 68,665 | Sold Some | -530 | -0.76 % | $2,971,821 | $1,620,494 | $-1,351,327 | -45.47 % | $10,430 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2008-02-14 | 2007-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 69,195 | No Change | 0 | 0 % | $2,666,083 | $1,633,002 | $-1,033,081 | -38.74 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2007-11-14 | 2007-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 69,195 | Added More | 500 | 0.72 % | $3,304,753 | $1,633,002 | $-1,671,751 | -50.58 % | $-12,080 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2007-08-10 | 2007-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 68,695 | Added More | 20,530 | 42.62 % | $2,854,964 | $1,621,202 | $-1,233,762 | -43.21 % | $-368,719 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2007-05-15 | 2007-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 48,165 | No Change | 0 | 0 % | $1,793,183 | $1,136,694 | $-656,489 | -36.61 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2007-02-14 | 2006-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 48,165 | Sold Some | -13,000 | -21.25 % | $1,685,293 | $1,136,694 | $-548,599 | -32.55 % | $148,070 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2006-11-14 | 2006-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 61,165 | No Change | 0 | 0 % | $1,773,173 | $1,443,494 | $-329,679 | -18.59 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2006-08-14 | 2006-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 61,165 | No Change | 0 | 0 % | $1,531,572 | $1,443,494 | $-88,078 | -5.75 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2006-05-15 | 2006-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 61,165 | Added More | 11,085 | 22.13 % | $1,592,125 | $1,443,494 | $-148,631 | -9.33 % | $-26,937 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2006-02-14 | 2005-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 50,080 | No Change | 0 | 0 % | $1,194,909 | $1,181,888 | $-13,021 | -1.08 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2005-11-10 | 2005-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 50,080 | No Change | 0 | 0 % | $966,544 | $1,181,888 | $215,344 | 22.27 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2005-08-08 | 2005-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 50,080 | Sold Some | -4,400 | -8.07 % | $837,338 | $1,181,888 | $344,550 | 41.14 % | $-30,272 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2005-05-05 | 2005-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 54,480 | Sold Some | -15,120 | -21.72 % | $909,271 | $1,285,728 | $376,457 | 41.40 % | $-104,479 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2005-02-10 | 2004-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 69,600 | Added More | 5,400 | 8.41 % | $1,572,960 | $1,642,560 | $69,600 | 4.42 % | $5,400 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2004-11-17 | 2004-09-30 | 13F-HR/A | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 64,200 | New Holding | 64,200 | 100 % | $1,227,504 | $1,515,120 | $287,616 | 23.43 % | $287,616 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2004-08-13 | 2004-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 0 | Sold All | -68,500 | -100 % | - | - | - | 81.39 % | $-725,415 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2004-05-12 | 2004-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 68,500 | Added More | 8,400 | 13.97 % | $1,199,435 | $1,616,600 | $417,165 | 34.78 % | $51,156 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2004-02-13 | 2003-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 60,100 | No Change | 0 | 0 % | $1,017,493 | $1,418,360 | $400,867 | 39.39 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2003-11-14 | 2003-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 60,100 | No Change | 0 | 0 % | $722,402 | $1,418,360 | $695,958 | 96.33 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2003-08-12 | 2003-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 60,100 | Sold Some | -7,500 | -11.09 % | $856,425 | $1,418,360 | $561,935 | 65.61 % | $-70,125 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2003-05-14 | 2003-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 67,600 | Added More | 5,400 | 8.68 % | $973,440 | $1,595,360 | $621,920 | 63.88 % | $49,680 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2003-02-11 | 2002-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 62,200 | Sold Some | -3,000 | -4.60 % | $681,712 | $1,467,920 | $786,208 | 115.32 % | $-37,920 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2002-11-14 | 2002-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 65,200 | Added More | 3,900 | 6.36 % | $1,214,676 | $1,538,720 | $324,044 | 26.67 % | $19,383 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2001-05-23 | 2001-03-31 | 13F-HR/A | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 61,300 | Added More | 40,700 | 197.57 % | $3,751,560 | $1,446,680 | $-2,304,880 | -61.43 % | $-1,530,320 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2000-05-12 | 2000-03-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 20,600 | Added More | 4,500 | 27.95 % | $1,598,972 | $486,160 | $-1,112,812 | -69.59 % | $-243,090 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 2000-02-11 | 1999-12-31 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 16,100 | Added More | 15,400 | 2200.00 % | $2,094,932 | $379,960 | $-1,714,972 | -81.86 % | $-1,640,408 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 1999-11-12 | 1999-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 700 | Added More | 200 | 40.00 % | $14,616 | $16,520 | $1,904 | 13.02 % | $544 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
| 1999-08-12 | 1999-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 500 | New Holding | 500 | 100 % | $5,190 | $11,800 | $6,610 | 127.36 % | $6,610 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Myriad Genetics Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |